Posting open letters with questions that are designed to be both open-ended, and for which one would not be willing to accept the answers anyway is a pointless exercise.
They keep paying TheraCour because TheraCour is providing the R&D services that NNVC needs in order to get a product (or set of products) into Clinical Testing and then into Production and Revenue Generation.
The TheraCour technology is mostly going to be valuable once the remaining technical hurdles are overcome in order to get production levels reliably into the Kg quantities. For now - even before production levels are achieved - the technology is valuable to NNVC because without it - getting to Clinical Testing for an ant-viral compounds would not happen.
Since TheraCour hasn't misrepresented itself to NNVC,.... what's there to sue about?
But - can't hurt to ask - even if one really should already know the answers.
News 
Market Data 
Discover 
AI
